Navigation Links
Genomic Health Announces Publication of Study Using Oncotype DX(R) in Node-Negative and Node-Positive Breast Cancer Patients Treated With Aromatase Inhibitors
Date:3/8/2010

The study used Oncotype DX to analyze tumor samples from 1,231 patients involved in the landmark ATAC (Arimidex®, Tamoxifen, Alone or in Combination) trial, which established the extensive use of aromatase inhibitors for adjuvant treatment of postmenopausal women with hormone receptor-positive breast cancer. Nine-year distant recurrence was assessed for women in the anastrozole and tamoxifen monotherapy arms of the ATAC trial, including patients with disease that had spread to the lymph nodes (0 nodes, 1-3 nodes and 4 or more nodes).

Researchers collected tumor blocks primarily from patients in the United Kingdom and tested the significance of adding the RS result to a clinical model consisting of age, tumor size, grade and treatment, as well Adjuvant! Online, a valid risk assessment tool that evaluates clinical variables to help physicians and patients assess the risks and benefits of getting additional therapy after surgery.

Results indicated that the RS result provided statistically significant prognostic value beyond that provided by Adjuvant! Online in node-negative (p<0.001) patients. While the study confirmed the performance of the RS result in a large contemporary patient population of postmenopausal hormone receptor-p
'/>"/>

SOURCE Genomic Health
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
2. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
3. Personalized Medicine - The Genomic Revolution in Cardiac Care
4. Virogenomics, Inc. Awarded $2 Million National Institute of Standards and Technology (NIST) Advanced Technology Program Grant to Develop Integrated Diagnostic Biosensors
5. Genomic Health Announces Preliminary Results From a Study of Oncotype DX(TM) in Node-Positive Breast Cancer Patients
6. Microarray Sequence Capture Speeds Large-Scale Resequencing of Targeted Genomic Regions
7. BiPar Genomic Biomarker Data Demonstrate Overexpression of PARP-1 Gene in Multiple Cancer Types
8. Genomic Health Announces Eight Oncotype DX(R) Studies to Be Presented at 30th Annual San Antonio Breast Cancer Symposium
9. Orion Genomics Announces the Discovery of Novel Breast Cancer Biomarkers
10. Genomic Health Announces Identification of Genes Associated With Colon Cancer Recurrence Across Multiple Studies
11. Transgenomic Announces New Contracts for Phase II Trials With Two Major Pharmaceutical Companies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... -- NxStage Medical, Inc. (Nasdaq: NXTM ), a leading ... H. Burbank , Chief Executive Officer, will present at the ... on Wednesday, March 11 th at 3:50 ... be made available at http://ir.nxstage.com  at the time ... NxStage Medical, Inc. (Nasdaq: NXTM ) is a ...
(Date:3/4/2015)... WASHINGTON , March 4, 2015  Mail-service ... consumers, employers and government health plans ... research released by the Pharmaceutical Care Management Association ... specialty drugs offers one of the easiest ways ... CEO Mark Merritt . "Policymakers should resist ...
(Date:3/4/2015)...   Aratana Therapeutics, Inc . (NASDAQ: ... licensing, development and commercialization of innovative biopharmaceutical products for ... the Barclays Global Healthcare Conference to be ... Hotel in Miami , FL.  ... and Chief Executive Officer of Aratana Therapeutics, will provide ...
Breaking Medicine Technology:NxStage to Present at the Barclays Capital Global Healthcare Conference 2PCMA: Report Shows High-Tech Specialty and Mail-Service Pharmacies Will Reduce Costs for Illinois Employers, Consumers and Public Programs by $11.8 Billion 2Aratana Therapeutics to Present at the Barclays Global Healthcare Conference 2
... Corporation, a Nevada corporation ("MusclePharm" or the "Company") (OTCBB: ... to announce MusclePharm,s preliminary financial results for the third ... preliminary basis, the Company expects unaudited gross revenues for ... $5,700,000, an increase of 305% as compared to gross ...
... PRUSSIA, Pa., Oct. 10, 2011 Medical Alarm Concepts ... first fully-monitored medical alarm system that allows the user ... announced that it has officially launched its new television ... (HM3) one of the leading producers of infomercials and ...
Cached Medicine Technology:MusclePharm Announces Preliminary Third Quarter 2011 Results 2MusclePharm Announces Preliminary Third Quarter 2011 Results 3Medical Alarm Concepts Accelerates Return of MediPendant™ to Airwaves - Well Financed Nationwide Campaign Moving Ahead 2Medical Alarm Concepts Accelerates Return of MediPendant™ to Airwaves - Well Financed Nationwide Campaign Moving Ahead 3Medical Alarm Concepts Accelerates Return of MediPendant™ to Airwaves - Well Financed Nationwide Campaign Moving Ahead 4
(Date:3/5/2015)... Hinton, W.Va. (PRWEB) March 05, 2015 ... looming, but rather here—and it’s a crisis that is ... , In order to stay on top of ... are partnering with PracticeLink to meet face-to-face with physicians ... Career Advancement Workshop and Job Fair series. , Physician ...
(Date:3/4/2015)... March 05, 2015 Understanding China’s New ... 1:30 p.m. – 3:00 p.m. EDT, http://www.fdanews.com/UnderstandingChinaMDRegs ... revamped regulations for medical devices in China. , ... devices — research and development, approval, manufacturing, distribution, and ... those currently in development as well as those that ...
(Date:3/4/2015)... 04, 2015 Imagine No Malaria’s 2014 World ... Care2 Innovator Award , an honor given to nonprofit causes ... the Nonprofit Technology Conference (NTC15) in Austin, Texas. ... Methodist Church in Austin, was on hand for the presentation; ... No Malaria. , Imagine No Malaria was one of five ...
(Date:3/4/2015)... The Asia-Pacific phthalic anhydride market is ... by 2019, at a CAGR of 5.9% during ... Browse through the TOC of Asia-Pacific Phthalic Anhydride ... segments, with the help of various tables and ... is a derivative of phthalic acid, which is ...
(Date:3/4/2015)... March 04, 2015 When people talk about ... top artists spread across numerous genres, the Houston Rodeo ... conversation. Each night during the annual livestock show and rodeo, ... to the other activities being held at the event. The ... of performers that will try and get the festival its ...
Breaking Medicine News(10 mins):Health News:Physician Shortage Crisis Worsening 2Health News:FDAnews Announces: Understanding China’s New Medical Device Regulations Webinar, March 26, 2015 2Health News:FDAnews Announces: Understanding China’s New Medical Device Regulations Webinar, March 26, 2015 3Health News:Imagine No Malaria Receives Care2 Innovator Award 2Health News:Imagine No Malaria Receives Care2 Innovator Award 3Health News:The Asia-Pacific Ohthalic Anhydride Market is Estimated to Reach $5,632.8 Million by 2019 - A Report by MicroMarket Monitor 2Health News:The Asia-Pacific Ohthalic Anhydride Market is Estimated to Reach $5,632.8 Million by 2019 - A Report by MicroMarket Monitor 3Health News:Cheap Houston Rodeo Tickets: Ticket Down Slashes Houston Rodeo Tickets for John Legend, Pitbull, Alan Jackson, Tim McGraw, Zac Brown Band, Fall Out Boy & Miranda Lambert 2Health News:Cheap Houston Rodeo Tickets: Ticket Down Slashes Houston Rodeo Tickets for John Legend, Pitbull, Alan Jackson, Tim McGraw, Zac Brown Band, Fall Out Boy & Miranda Lambert 3
... ... ... , ... ...
... , ... ... , , , , ... ...
... ... ... , ... , , ...
... bone-building drugs used to prevent and treat osteoporosis may be at ... researchers published today in the British Journal of Cancer. , ... Fosamax, Boniva and Zomita, for more than two years had a ... did not, according to lead author Polly Newcomb, Ph.D., M.P.H., head ...
... who used them lost weight, lowered heart disease risk, ... Workplace wellness programs help employees lose weight and reduce ... , U.S. researchers followed 757 hospital workers who took ... focused on diet and exercise. Data on the participants, ...
... ... ... , ... , , , ...
Cached Medicine News:Health News:Pelosi Remarks at Press Availability on Health Insurance Reform 2Health News:Pelosi Remarks at Press Availability on Health Insurance Reform 3Health News:Pelosi Remarks at Press Availability on Health Insurance Reform 4Health News:Pelosi Remarks at Press Availability on Health Insurance Reform 5Health News:KV Pharmaceutical Subsidiary Pleads Guilty to Two Felonies Regarding Oversized Drugs 2Health News:KV Pharmaceutical Subsidiary Pleads Guilty to Two Felonies Regarding Oversized Drugs 3Health News:KV Pharmaceutical Subsidiary Pleads Guilty to Two Felonies Regarding Oversized Drugs 4Health News:Philadelphia Phillies Host Tug McGraw Foundation to Raise Awareness for Brain Tumors 2Health News:Philadelphia Phillies Host Tug McGraw Foundation to Raise Awareness for Brain Tumors 3Health News:Common osteoporosis drugs are associated with a decrease in risk of breast cancer 2Health News:Workplace Wellness Programs Work 2Health News:Star of TV's The Doctors Helping Put Smiles on Faces of Needy Children in India 2Health News:Star of TV's The Doctors Helping Put Smiles on Faces of Needy Children in India 3
... The Nellcor N-20PA Handheld Pulse Oximeter ... dependability. The durable construction of the N-20PA ... extreme temperatures and conditions it has ... It is conveniently portable for spot check ...
... Nellcor NPB-290 and NPB-295 Pulse Oximeters ... provide accuracy, reliability and proven signal ... poorly perfused patients. Equipped with Oxismart ... Technology, these pulse oximeters identify electronic ...
... the growing portfolio of OxiMax® monitors, ... a compact, affordable bedside monitor. Equipped ... technology, it offers reliable operation during ... with the complete family of innovative ...
The Model 5305 is a hand-held, portable, lightweight pulse oximeter designed for spot checking. It has a NiCad rechargeable battery....
Medicine Products: